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Summary
Background.— Myocardial infarction is rarely caused by non-occlusive thrombus in angiograph-
ically normal coronary arteries. The cases reported in the literature are scarce and follow-up
was usually short. The efﬁcacy and tolerability of the exclusively medical treatment strategy
used in most cases remain unknown.
Aims.— To evaluate efﬁcacy of medical treatment and long-term prognosis in these patients.
Methods.— We retrospectively selected and analysed patients hospitalized in our centre
between 1998 and 2008 for myocardial infarction caused by non-occlusive thrombus in angio-
graphically normal coronary arteries (deﬁned as stenosis < 30%), who were exclusively medically
treated. A long-term follow-up was performed. A review of the literature regarding such cases
was carried out.
Results.— Sixteen patients were identiﬁed; apart from smoking, they had few conventional
cardiovascular risk factors. Two patients died in hospital. The 14 survivors were followed up
for an average of 4.9 years and only one death (non-cardiac cause) and one stroke (related to
supraventricular arrhythmia) occurred in this period. Medical treatment included the use of gly-
coprotein IIb/IIIa inhibitors in 75% of cases. The literature review revealed 36 similar cases due
to multiple aetiologies—particularly coronary artery spasm and prothrombotic coagulopathies.
Conclusion.— Patients withmyocardial infarction secondary to non-occlusive thrombus in angio-
graphically normal coronary arteries seem to have a good long-term prognosis after the acute
phase when treated with an exclusively medical strategy. However, initial clinical presentation
was often severe, leading to early in-hospital death.
© 2011 Elsevier Masson SAS. All rights reserved.
Abbreviations: TIMI, Thrombolysis in myocardial infarction.
∗ Corresponding author. Fax: +33 2 31 06 44 18.
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Résumé
Contexte.— Les infarctus du myocarde peuvent, rarement, être causés par des thrombus non
occlusifs sur des coronaires angiographiquement normales. Les cas rapportés dans la littérature
ont été rares et leur suivi souvent court. L’efﬁcacité et la tolérance du traitement médical
exclusif, utilisé dans la plupart des cas, restent inconnues.
Objectif.— Évaluer l’efﬁcacité du traitement médical et le pronostic à long terme chez ces
patients.
Méthode.— Nous avons rétrospectivement sélectionné et analysé les patients hospitalisés dans
notre centre, entre 1998 et 2008, pour un infarctus du myocarde causé par un thrombus non
occlusif sur coronaires angiographiquement normales déﬁnies par des sténoses inférieures ou
égales à 30% et traités exclusivement médicalement. Un suivi à long terme a été effectué. Une
revue de la littérature sur les cas similaires a été réalisée.
Résultats.— Seize patients ont été identiﬁés et hormis le tabagisme, ils avaient peu de facteurs
de risques cardiovasculaires conventionnels. Deux patients sont décédés à l’hôpital. Les 14
survivants ont été suivis pendant 4,9 ans en moyenne, un décès de cause non cardiaque et un
accident vasculaire cérébral relatif à un trouble du rythme supraventriculaire ont eu lieu. Le
traitement médical comprenait l’utilisation des inhibiteurs des GPIIb/IIIa dans 75 % des cas.
La revue de la littérature a révélé 36 cas similaires aux étiologies multiples, en particulier le
spasme coronaire et les coagulopathies prothrombotiques.
Conclusion.— Les patients avec infarctus du myocarde secondaire à un thrombus non occlusif
sur coronaires angiographiquement normales semblent avoir un excellent pronostic à long terme
après la phase aiguë lorsqu’ils ont été traités exclusivement médicalement mais la présentation
clinique initiale fut souvent sévère conduisant à des décès hospitaliers précoces.
© 2011 Elsevier Masson SAS. Tous droits réservés.
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Acute coronary syndromes include several clinical and
anatomical aspects of coronary disease, especially includ-
ing intracoronary thrombus. Percutaneous revascularization
of thrombus-containing lesions is associated with increased
incidence of death and myocardial infarction [1]. However,
intracoronary non-occlusive thrombi were rarely observed
in patients without angiographic coronary lesions and have
previously been proposed as a possible cause of myocar-
dial infarction in those with normal coronary arteries [2].
The development of interventional cardiology allowed these
thrombi to be identiﬁed in the acute phase of coronary
syndromes. In the literature, case reports were scarce and
follow-up was usually for less than 6months. Exclusively
medical treatment was used in most cases but its efﬁciency
and tolerability remain unknown. Our study investigated
the characteristics, aetiologies and long-term follow-up of
patients with intracoronary non-occlusive thrombus without
angiographic coronary lesions, who were medically treated
in the acute phase. A review of the literature reporting such
cases was performed.
Methods
Our studyPatients who were admitted to our institution with myocar-
dial infarction with or without ST-segment elevation were
screened retrospectively from January 1998 to October
2008. Coronary angiograms were reviewed by two inde-
r
l
c
lendent experienced angiographers. Sixteen patients were
dentiﬁed who had intracoronary thrombus without signif-
cant coronary stenosis (angiographically deﬁned as more
han 30%) and received exclusively medical treatment during
he acute phase. The angiographic presence of a throm-
us was deﬁned as a non-calciﬁed ﬁlling defect outlined
n at least three sides by contrast media. We included
atients with thrombus greater or equal to grade 2 [3],
hrombolysis in myocardial infarction (TIMI) ﬂow 2 or 3
4] and without signiﬁcant coronary lesions (underlying
r throughout the coronary tree; Fig. 1). Patients were
xcluded for the following reasons: if doubt remained
bout the underlying coronary lesion due to the thrombus
eing afﬁxed to the artery wall; if they had an anatomical
bnormality of the coronary arteries (dissection, ecta-
ia); if they had thrombosis during the procedure; or if
hey required balloon angioplasty or stenting in the acute
hase.
Age, sex, cardiovascular risk factors and left ventricular
jection fraction were recorded. Clinical conditions known
o be associated with hypercoagulation, such as pregnancy,
ral contraceptive or drug use, were searched for systemat-
cally. Coronary angiograms and treatments were detailed.
Follow-up was performed by telephone questioning of the
atient’s general practitioner and cardiologist in February
009. In case of lack of information this could be com-
leted by interviewing the patients. The following data
ere analysed: death (cardiac death or all-cause mortality),
ecurrence of myocardial infarction, need for revascu-
arization, heart failure, ventricular arrhythmia, bleeding
omplication, stroke, thromboembolic event, left ventricu-
ar ejection fraction and medical treatment.
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Figure 1. Coronary angiogram showing non-occlusive thrombus in
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Table 1 Clinical and therapeutic characteristics of the
patients in our cohort.
Characteristic
Baseline characteristics
at admission (n = 16)
Men 11 (69)
Previous angina
pectoris
0
Systemic hypertension 5 (31)
Diabetes mellitus 0
Hyperlipidaemia 2 (12.5)
Current smoker 9 (56)
Family history of
coronary disease
3 (19)
Systolic blood pressure
(mmHg)
121± 18
Diastolic blood
pressure (mmHg)
76± 11
Pulse (beats per
minute)
72± 12
Heart failure 4 (25)
Electrocardiogram
ST-segment
elevation
9 (56)
Non-ST-segment
elevation
7 (44)
Cardiogenic shock 3 (19)
Pharmacological
treatments in acute
phase
Thrombolytic agents
(patients with
ST-segment elevation)
2/9 (22)
Unfractionated
heparin
13 (81)
Low-molecular-weight
heparins
3 (19)
Aspirin 15 (94)
Aspirin + clopidogrel or
ticlopidine
11 (69)
Glycoprotein IIb/IIIa
inhibitors
12 (75)
In-hospital deaths 2 (12.5)
Pharmacological
treatments at discharge
(n = 14)
Aspirin 14 (100)
Beta-blockers 14 (100)
Angiotensin-converting
enzyme inhibitors
11 (79)
Statins 13 (93)
Low-molecular-weight
heparins
10 (71)
Aspirin + clopidogrel or
ticlopidine
12 (86)
Values are mean± standard deviation or number of patientshe proximal left anterior descending artery without stenosis in one
f our patients.
eview of the literature
e conducted a manual review of case reports using the
ubMed database. Unrestricted database searches until
anuary 2009 were performed using the Medical Subject
eadings (MeSH) term ‘‘coronary thrombosis’’. Article ref-
rences were reviewed in order not to miss other case
eports. Some articles had several case reports, of which
nly one was selected.
We included case reports on patients with ST-segment
r non-ST-segment elevation myocardial infarction, with
ngiographically conﬁrmed thrombus greater or equal to
rade 2, without proximal occlusion on the thrombus and
ith angiographically normal coronary arteries. Studies
ith insufﬁcient information and those involving patients
ith angiographically atheromatous coronary lesions greater
han 30%, anatomical abnormalities of the coronary arter-
es (dissection, ectasia), thrombosis during the procedure or
ost-mortem-visualized thrombus were excluded.
The following information was extracted from each
tudy: ﬁrst author; year of publication; journal; patient
haracteristics (sex, age, cardiovascular risk factors, Killip
lass); electrocardiogram; coagulation analyses; left ven-
ricular ejection fraction; thrombus TIMI grade; localization;
resence of distal embolizations; treatment; possible coro-
ary angiography control; aetiology; and follow-up.
After a review of 1261 published articles, 196 were read
n detail and 36 articles were ﬁnally selected (Fig. 2). Similar
ases were published by Burzotta et al. [5] but were not
ncluded in this review because the patients were treated in
ur institution and were therefore included in our cohort.
tatistical analysisll continuous variables are expressed as mean val-
es± standard deviations. Categorical variables are
xpressed as numbers of patients or percentages.
(%).
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Table 2 Coronary angiogram characteristics in our
cohort (n = 16).
Coronary angiogram
characteristics
Number of patients (%)
Thrombus grade
Grade 1 0
Grade 2 1 (6)
Grade 3 7 (44)
Grade 4 8 (50)
Location
Left anterior
descending coronary
artery
7 (44)
Circumﬂex coronary
artery
1 (6)
Right coronary artery 7 (44)
Left main coronary
artery
1 (6)
TIMI grade ﬂow
TIMI 2 3 (19)
TIMI 3 13 (81)
Distal embolization 3 (19)
Multiple thrombi 1 (6)
TIMI: thrombolysis in myocardial infarction.
Table 3 Follow-up of our patients.
Number of patients (%)
Clinical events (n = 14)
Death
All causes 1 (7)
Cardiac causes 0
Recurrence of
myocardial infarction
0
Revascularization 0
Heart failure 0
Ventricular
arrhythmias
0
Stroke 1 (7)
Thromboembolic
events
0
Bleeding complications 0
Pharmacological
treatments (n = 12)
Aspirin or clopidogrel 11 (92)
Aspirin + clopidogrel 2 (17)
Beta-blockers 12 (100)
Angiotensin-converting
enzyme inhibitors
7 (58)
Statins 12 (100)
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Our cohort included 11 men and ﬁve women, with a mean
age of 48± 14 years. Mean body mass index was 26.4± 4.8
(half had a body mass index > 25). Mean left ventricular ejec-
tion fraction was 56.8± 14.2% (range 20—76%). None of the
patients had previous angina and more than 50% presented
with ST-segment elevation on electrocardiogram at admis-
sion. Patient demographics and clinical characteristics at
admission are summarized in Table 1. The TIMI risk score [4]
was less or equal to 3 for all patients and the mean Global
Registry of Acute Coronary Events (GRACE) score [6] was
90± 27.
All patients received curative anticoagulation in the
acute phase and 75% received glycoprotein IIb/IIIa inhibitors
for at least 12 hours. Seventy-one percent of the survivors
received low-molecular-weight heparins for at least 7 days.
All patients received aspirin and 86% had both aspirin and
clopidogrel or ticlopidine at discharge (Table 1).
Blood analysis showed severe renal insufﬁciency in one
patient and slight renal insufﬁciency in four patients. Coagu-
lation disorders were investigated in only three patients; the
results were negative. One patient was treated for essen-
tial thrombocythaemia. Homocysteinaemia was analysed in
half of our cohort; results were normal. Mean ﬁbrinogen was
3.6± 1.5 g/L (range 2.1—6.8 g/L).
Retrospective analysis of coronary angiograms showed
mostly high-grade thrombi (Table 2). Coronary angiogram
control was done in nine patients. Of the four controls done
on day one, three showed persistent thrombi. The thrombi
had disappeared on all controls done after the third day of
hospitalization.
t
O
wAetiologies were suspected in eight patients (Fig. 3).
mong patients with a found aetiology, one patient aged
1 years had presented with a stroke 6 years earlier but died
ithin the ﬁrst 24 hours and it was not possible to obtain
complete coagulation analysis. No patient was human
mmunodeﬁciency virus positive. Among patients without a
ound aetiology, ﬁve had cardiovascular risk factors other
han smoking and ﬁve were smokers versus three and four,
espectively, among patients with a found aetiology.
Two patients died in hospital: the ﬁrst after 24 hours
ue to refractory shock after left ventricular assistance
or irreducible ventricular ﬁbrillation and the second after
months due to septic shock. Mean follow-up was 4.9 years
range 6months to 10 years) for the remaining 14 patients.
ne patient died 6 years later from a non-cardiac cause
septic shock in myeloproliferative syndrome secondary to
hrombocytosis). One patient presented with a stroke in
trial ﬁbrillation 3 years after myocardial infarction. All
atients recovered a normal left ventricular ejection frac-
ion (63.3± 5.7%). Events and treatment during follow-up
re summarized in Table 3.
In our review of the literature (Table 4), the patients
escribed were young (mean age: 36.3± 10.7 years). Eigh-
een were smokers but only ﬁve had another cardiovascular
isk factor. Only one third of the patients had biological tests
o search for coagulation disorders (10/36) or a previous
nown coagulation disorder (2/36). Distal embolization was
bserved in 20 cases. Coronary angiograms controls done
ithin the ﬁrst 72 hours after admission showed persistent
hrombi in four cases and total disappearance in 10 cases.
nly one patient died during hospitalization and no events
ere reported in patients monitored after hospitalization.
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Table 4 Review of case reports with cardiovascular risk factors, coronary angiogram characteristics, treatment, aetiologies and follow-up.
Case reports Sex Age CVRF Smoker Thrombus
grade
Location Treatment Asp Clop-Ticl Hep GP inh Throm OAT Follow-up
(months)
Aetiologies
Acar et al.
(2008) [27]
M 55 No No 4 RCA 1 Medical Yes Yes Yes Yes No No 6 -
Atmaca et al.
(2007) [28]
M 54 No No 4 LAD 1 Medical Yes No Yes Yes Yes Yes 0 Coronary
embolism
Bashour TT
et al. (1994)
[29]
W 29 Yes Yes 4 LAD 1 Medical Yes No Yes No No No 0 Coronary
spasm
Bashour TT
et al. (1990)
[30]
M 35 No Yes 4 LAD 1 Medical Yes No Yes No No Yes 0 Coronary
spasm
Bauters et al.
(2002) [31]
M 28 No No 4 LAD 1 Medical Yes Yes Yes Yes Yes No 3 Myocardial
bridging
Bickel et al.
(2002) [32]
W 35 Nr Nr 3 Bif LAD-LCX Medical Yes Yes Yes Yes No Nr 0 -
Cay et al.
(2006) [33]
M 39 Nr Nr 4 RCA 3 Medical Yes Nr Yes Yes No Yes 0 Coronary
embolism
Ciraulo et al.
(1979) [34]
W 36 No No 3 Marg 1 Medical Nr Nr Nr Nr Nr Nr 0 After
pregnancy
Corre et al.
(2002) [35]
M 25 No No Nr LAD 1 Medical Nr Nr Nr Nr Nr Nr 0 Factor V
Leiden
mutation
Dagdelen
et al. (2001)
[36]
W 47 No No 4 LAD 2 Medical Yes No Yes Yes Yes Yes 2 Coronary
spasm
Doshi et al.
(2003) [37]
M 38 No Yes 3 LAD 1 Medical Yes No Yes Yes No No 0 Cocaine use
Eggebrecht
et al. (2002)
[18]
M 32 Yes Yes 4 LAD 1 Medical +
Thrombec
Nr Nr Yes Yes No No 0 Sumatriptan
Feit et al.
(1988) [38]
M 32 No Yes 3 LAD 1 +RCA 1 Medical Nr Nr Yes No Yes Yes 24 -
Germing et al.
(2006) [39]
W 37 No Yes 4 Bif LAD-LCX Medical Yes Yes Yes Yes Yes No 14 -
Guo et al.
(2007) [40]
W 41 No No 3 LAD 2 Medical Yes No Yes No No No 0 Myocardial
bridging
Throm
bus
in
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Haude et al.
(1998) [20]
M 43 Yes Yes 3 LAD 1 Medical +
Angiopl
Yes Yes Yes Yes Yes No 6 -
Kaykcoglu
et al. (2005)
[41]
M 29 No Yes - Bif LAD-Dg 1 Medical Yes Yes - No Yes No 9 Factor V
Leiden
mutation
Klein AJ et al.
(2008) [22]
M 44 Nr Nr 2 LAD 2 Medical Yes No Yes Yes No Yes 3 -
Klein KL et al.
(1989) [42]
M 36 No Yes 4 RCA 2 Medical Nr Nr Yes No Yes Yes 6 Paroxysmal
nocturnal
haemoglobinuria
Kosar et al.
(2003) [43]
M 43 No No 3 Bif LAD-Dg1 Medical Yes No Yes No No Yes 3 Coronary
embolism
Kurisu et al.
(2004) [24]
M 28 No Yes 4 LAD 1 Medical Yes No Yes No Yes Yes 0 Myocardial
bridging
Kutom et al.
(1991) [44]
W 26 No No 3 LAD 1 Medical Yes Nr Nr No No Yes 3 Lupus
Marcu et al.
(2005) [21]
W 51 Yes No 4 RVP Medical +
Angiopl
Yes No Yes No No Yes 3 Coronary
embolism
Ment et al.
(2002) [25]
M 23 Yes Yes 4 LAD 1, 2 & 3 Medical Yes No Yes Yes No No 0 Anabolic
steroid use
Moriuchi et al.
(1989) [45]
M 37 No Yes 2 LAD 1 Medical Nr Yes Nr Nr Yes Nr 36 -
Nakagawa
et al. (1994)
[46]
W 54 No No 3 LAD 2 +RCA 1 Medical Nr Nr Nr Nr Yes Nr 0 Progesterone +
tamoxifen
Pamplona
et al. (1997)
[47]
M 35 No Yes 4 LAD 3 + LCX
2 +RCA 2
Medical Yes No Yes No Yes No 0 Heavy alcohol
ingestion
Parry et al.
(1992) [48]
W 27 No No 2 LAD 1 Medical Yes No Yes No No Yes 3 Still’s
disease + after
pregnancy
Penny et al.
(1985) [49]
W 17 No Yes 4 LAD 3 + LCX 3 Medical No No Nr No No Yes 3 Factor XII
deﬁciency
Rod et al.
(1986) [50]
M 32 No No 4 LAD 1 Medical Nr Nr Yes No Yes Nr 0 Cocaine use
Schlaifer et al.
(2001) [51]
W 36 Nr Nr 4 LMCA Medical Yes No Yes Yes No Yes 24 Antiphospholipid
antibodies
syndrome
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iscussion
ur study showed that patients with myocardial infarction
econdary to non-occlusive thrombus in angiographically
ormal coronary arteries had a good long-term prognosis
fter the acute phase but that initial clinical presentation
as often severe, leading to early in-hospital death. This
volution was obtained with exclusively medical treatment
n our cohort.
Our patients appeared somewhat different from patients
ncluded in acute coronary syndrome trials, as they were
ounger [2] and presented with few cardiovascular risk fac-
ors, apart from smoking. Cigarette smoking is known to
romote atherosclerosis but also inﬂammation, coronary
asospasm and thrombosis, increasing platelet aggregability
nd ﬁbrinogen levels, and altering ﬁbrinolysis mechanisms
7]. Our cohort was clinically close to those described in
yocardial infarction with normal coronary arteries [8].
ntracoronary thrombi were considered as a possible cause
f myocardial infarction in patients with normal coronary
rteries, with thrombus lysis before coronary angiogram
xplaining the absence of possible thrombus [2].
We have proposed an algorithm to summarize the dif-
erent aetiologies found in our cohort and in the literature
Fig. 4). Coagulation disorders promoting thrombosis, such
s thrombocytosis in one of our patients, were a major
ause. Thrombophilia, including antiphospholipid antibod-
es syndrome, was traditionally associated with venous
hrombosis but must be sought in young patients present-
ng with coronary thrombosis without atherosclerotic signs
9,10]. Previous studies of patients with myocardial infarc-
ion with normal coronary arteries reported an increased
revalence of genetic prothrombotic factors or coagula-
ion abnormalities [8,11] that were underestimated in our
ohort and probably in the literature because some of the
ublished cases were old and because the frequency of com-
lete coagulation assessments was low. Coronary vasospasm
ight promote thrombi by reducing the lumen diameter
nd also blood ﬂow; it can be provoked by several sub-
tances, such as cocaine, cigarettes, cannabis and alcohol.
owever, no provocation test was done in our cohort. Mas-
ive alcohol intake was proposed as a possible cause in two
atients in our cohort, as this can promote thrombi due
o intense vasospasm [12]. Inﬂammation during severe sep-
is was another aetiology; during severe sepsis, endotoxins
timulate the expression of genes encoding procoagulant
olecules and the endothelial cell production of the ﬁb-
inolytic inhibitor plasminogen activator inhibitor-1 [13].
ormonal changes with oestroprogestative therapy or preg-
ancy have been shown to be associated with an increased
isk of arterial thrombosis [14]. We found one case of
naemia related to vitamin B12 deﬁciency in our cohort.
itamin B12 was negatively correlated with total homocys-
eine, a known thrombosis risk factor due to its actions on
oagulation and endothelial function [15]; its role in our
atient was hypothetical. Finally, we must underline that
therosclerosis might represent a cause in some patients. In
ur cohort, patients without a found aetiology had more car-
iovascular risk factors. The coronary arteries were deﬁned
s normal using coronary angiography and it is possible that
laque rupture or endothelial erosion causing thrombus may
ave been missed on the coronary angiogram.
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pFigure 2. Flow diagram for case report selection.
Our study showed good long-term prognosis in hospital
survivors. We found a global survival of 93% after hospital-
ization with a mean follow-up of 5 years, which was close to
survival described for patients who had an acute myocardial
infarction with angiographically normal coronary arteries
(between 95.5% at 3 years [8] and 100% at 10 years accord-
ing to the studies [16]). In contrast, studies of myocardial
infarction irrespective of the importance of coronary lesions
showed a dramatically worse long-term prognosis [6]. How-
ever, in the acute phase, more than half of our patients
presented with ST-segment elevation myocardial infarction
and cardiogenic shock was present in two of our patients.
The absence of preconditioning in our patients, who were
t
t
k
Figure 3. Distribution of suspected aetiologies in our cohort.oung and had no previous angina, could explain hospital
ortality [17]. Long-term, one of our patients died from
yeloproliferative syndrome secondary to thrombocytosis,
howing the importance of the aetiologies in this syndrome.
owever, survival without cardiac events after hospitaliza-
ion was 100% for our patients. In the literature, no events
ave been reported in the follow-up of patients, at least at
id-term.
All of our patients were medically treated in the acute
hase. Other therapeutic strategies, including thrombec-
omy in two cases [18,19] and balloon angioplasty in
wo other cases [20,21], were rarely used in the same
ind of patient, but were successful. Despite aggressive
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cigure 4. Proposed algorithm of aetiologies of thrombus in angiogr
hrombus in the same patient could have multiple aetiologies.
nticoagulant and antiaggregant treatment, we observed no
aemorrhagic complications in our cohort; their young age
nd few haemorrhagic risk factors justiﬁed aggressive med-
cal treatment. Glycoprotein IIb/IIIa inhibitors were widely
sed in our study and probably brought an additional beneﬁt,
romoting thrombus lysis [3].
A coronary angiogram control was done in most cases.
his control aimed to ensure the absence of underlying
oronary lesions, which can be hidden by thrombi in the
cute phase. Intravascular ultrasound analysis was not done,
nfortunately, but can be recommended in these patients
o gain a better understanding of pathophysiology and to
void missing inconspicuous atherosclerosis. Thrombus per-
istence was not correlated with later evolution in our study.
requency of persistent thrombi during the ﬁrst 48 hours
ssociated with embolic risk during the procedure should
epresent an incentive to extend these controls beyond
2 hours in the absence of clinical instability.
m
a
hally normal coronary arteries. It should be noted that intracoronary
tudy limitations
e studied a speciﬁc population of patients with intracoro-
ary thrombus in angiographically normal coronary arteries
r without signiﬁcant lesions (> 30%), excluding occlusive
hrombi. Poor visualization of the distal coronary artery and
otential underlying lesions justiﬁes the decision to exclude
cclusive thrombi. Moreover, in the acute phase of myocar-
ial infarction, the coronary artery must be reopened and
ngioplasty will be mandatory in most cases.
One of the main limitations was the small size of our
ohort. However, as evidenced by review of the literature,
ur cohort is the largest reported to date with this speciﬁc
linical entity.In our study, the coronary arteries were deﬁned as nor-
al using coronary angiography, which may misidentify
therosclerotic plaques with outward growth. No patients
ad angiographic evidence of plaque rupture. Systematic
nd r
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[Thrombus in normal coronary arteries: Retrospective study a
intravascular ultrasound analysis was impossible due to
the retrospective nature of this study; it was carried out
in six patients in the literature, showing an absence of
atherosclerosis in two cases [22,23] and inconspicuous signs
of atherosclerosis in the other cases [18,20,24,25]. Phys-
iopathological mechanisms causing these thrombi may be
different from classical plaque rupture. Endothelial dys-
function, the importance of which has been emphasized in
patients with or without coronary lesions [26], may play a
leading role.
Conclusion
In our study and in the literature, patients with myocardial
infarction secondary to non-occlusive thrombus in angio-
graphically normal coronary arteries seem to have a good
long-term prognosis after the acute phase, but clinical
presentation was often severe leading to early in-hospital
death. Our conclusions should be tempered by the small
number of patients described. Exclusively medical treat-
ment in our patients showed excellent long-term tolerability
and efﬁciency. Many aetiologies, most of which are cur-
able, should be searched for, with detailed examination and
coagulation tests. There were numerous pathophysiological
underlying mechanisms, probably associated with and simi-
lar to those described for myocardial infarction with normal
coronary arteries, of which our cohort was probably a sub-
group.
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